Stock Split News

SALT LAKE CITY--(BUSINESS WIRE)--BRC Inc. (NYSE: BRCC) (“Black Rifle Coffee Company” or the “Company”), a Veteran-founded, mission-driven premium coffee company, today announced that the Company expects to effect a 1-for-10 reverse stock split (the “Reverse Stock Split”) of the Company’s Class A common stock and Class B common stock on August 21, 2026 (the “Effective Date”). The Reverse Stock Split of the Class A common stock is expected to become effective at 5:01 p.m. Eastern Time on the Effe...

WALLINGFORD, Conn.--(BUSINESS WIRE)--Amphenol Corporation (NYSE: APH) today announced that at its meeting held on August 5, 2026, the Company’s Board of Directors approved a two-for-one stock split to be paid in the form of a stock dividend. Each Amphenol shareholder of record at the close of business on August 17, 2026 will receive one additional share for every share held on the record date. Amphenol expects the additional shares will be distributed on September 2, 2026. Following the two-for...

MONTPELLIER, France & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announces the implementation of the reverse share split of its shares. The reverse share split will result in the exchange of 50 existing shares of €0.10 par value (the "Existing Shares") for 1 new share of €5 par value (a "New Sha...

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS) (the “Company” or “Gossamer”), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), announced a series of regulatory, strategic, and corporate updates. Following a productive Pre-NDA Type B meeting with the U.S. Food and Drug Administration (FDA)...

LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future,” “FF” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, announced today that it will effect a 1-for-150 reverse split of its Class A common stock (the “Class A Common Stock”) and Class B common stock, each with par value of $0.0001 per share. Commencing with the opening of trading on the Nasdaq Capital Market on July 24, 2026, the Company’s Class A Common Stock...

LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future,” “FF” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, announced today that it will effect a 1-for-150 reverse split of its Class A common stock (the “Class A Common Stock”) and Class B common stock, each with par value of $0.0001 per share. Commencing with the opening of trading on the Nasdaq Capital Market on July 24, 2026, the Company’s Class A Common Stock...

BLOOMSBURG, Pa.--(BUSINESS WIRE)--Muncy Columbia Financial Corporation (“Corporation”) (OTCQX: CCFN), parent company of Journey Bank (“Bank”), has released its unaudited consolidated financial results for the second quarter of 2026. Unaudited Financial Information Net income, as reported under accounting principles generally accepted in the United States of America (“GAAP”), for the second quarter 2026 was $7,155,000, or $0.67 per share, compared to $5,768,000, or $0.54 per share, for the secon...

AUSTIN, Texas--(BUSINESS WIRE)--DBGI Corp. (NASDAQ:DBGI) (the “Company”), a publicly traded company specializing in eCommerce and fashion, today announced to solidify its long-term market footing, that it will effect a 1-for-40 reverse stock split (the “Reverse Stock Split”) of its common stock, par value $0.0001 per share (“Common Stock”).The Reverse Stock Split is intended to increase the closing bid price of the Common Stock above $1.00 per share, and to enable the Company to manage continued...

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced that on July 15, 2026, it granted options to purchase an aggregate of 160,000 shares of DiaMedica’s common stock to a newly hired non-executive employee whose employment commenced in July 2026. The stock options were a material inducement to the employee’s...

MEMPHIS, Tenn.--(BUSINESS WIRE)--FedEx Corp. (NYSE: FDX) (“FedEx”) today announced the pricing terms of its previously announced cash tender offers (each, an “Offer” and, collectively, the “Offers”) to purchase up to $4,150,000,000 aggregate purchase price, not including accrued and unpaid interest (the “Offer Cap”), of FedEx’s validly tendered (and not validly withdrawn) notes set forth below (collectively, the “Notes”), using a “waterfall” methodology under which FedEx will accept the Notes i...